last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost C$10,000 or more per year [eg, antivirals or biologics for rheumatoid arthritis or crohn’s disease]. over the past five years, the top increases in drug spending were for drug classes with average annual costs of C$10,000 or more.

the proportion of public drug dollars being spent on high cost drugs continues to grow. while new drugs and higher use of drugs can increase spending, factors like drug pricing policies and further uptake of biosimilars could lead to… Click To Tweet

read the report here